In-vitro Colorectal Cancer Screening Tests Market: Strategies & Insights, & Recent Developments

Global In-vitro Colorectal Cancer Screening Tests Market: Snapshot
Diagnostic tools have undergone a sea change in the recent decades, owing to the rapidly growing demand for non-invasive diagnostics that are efficient as well as fast. Compliance with these demands ensures that the tools provide a relatively higher ease of operation and also promote better patient compliance and test results. They are also a lot easier to use for medical professionals and do not restrict a patient to any dietary compulsions. The growing number of non-invasive surgical and diagnostic tools is therefore, a massive boon to the growth of the global market for in-vitro colorectal cancer screening testing.
Another factor that promotes this market’s growth is the growing prevalence of syndromes and diseases that are inherited. A rise in their number directly implies an increasing demand for testing procedures for diseases such as cancer.
This 95 page report gives readers a comprehensive overview of the in-vitro colorectal cancer screening testing market. Browse to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/in-vitro-colorectal-cancer-screening-tests-market.html
The in-vitro colorectal cancer screening testing companies, however, have to go through a highly stringent set of regulations to be able to make their products and tests available for use. The high amount of regulatory pressure not only complicates matters for key players, but also makes it difficult for new entrants to penetrate the market.
Owing to such factors, the global market for in-vitro colorectal cancer screening testing is expected to reach a revenue of US$602.3 mn by the end of 2016 and US$980.6 mn by 2023. It is expected to progress at a CAGR of 7.5% from 2015 to 2023.
North America Demand for In-vitro Colorectal Cancer Screening Testing to Remain Highest
By the end of 2023, North America is expected to generate revenues of US$316.7 mn from in-vitro colorectal cancer screening testing. As per the findings released by the American Cancer Society, in 2015 more than 93,000 new cases of colon cancer and more than 39,000 cases of rectal cancer were diagnosed in the U.S. alone. The North American region also holds one of the largest population pools of elderly citizens, a demographic that is very prone to such diseases. These are the key reasons for the high demand for in-vitro colorectal cancer screening testing shown by the region.
Meanwhile, the demand for in-vitro colorectal cancer screening testing is expected to increase at a very high rate in Europe, owing to the increasing number of the elderly and the growing availability of advanced and automated diagnostic tools and techniques.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving in-vitro colorectal cancer screening testing market during 2015 - 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3698
Fecal Occult Blood Tests to Continue Taking up Sizeable Shares in Revenue
By the end of 2023, US$567.7 mn is expected to be generated within the test segment of fecal occult blood testing. Colorectal cancer – considered as the third largest cancer related cause of death by the ACS – can be diagnosed through fecal occult blood tests, blood biomarker tests, and stool biomarker tests. Of these, fecal occult blood (FOB) testing has been the most commonly used diagnostic measure, owing to its older presence in the healthcare industry coupled with its lower price than modern means. Guaiac FOB stool tests have been the most popular FOB tests used across the globe so far. On the other hand, the demand for blood biomarker tests is expected to increase at the highest rate till 2023, owing to the rapidly growing preference for tests such as the Epi proColon test.
The key providers of in-vitro colorectal cancer screening testing are Beckman Coulter, Inc., Sysmex Corporation, Alere, Inc., Abbott Molecular, Inc., Quest Diagnostics, Inc., and Biotime, Inc.

Europe Molecular Diagnostics Market Trends And Opportunities For The Industry By 2025

Transparency Market Research (TMR) observes that the Europe molecular diagnostics market is likely to see intensifying competition due to large number of players in the market. Companies are expected to focus on product differentiations and customizations to remain relevant in the competition. Thermo Fishcer Scientific and Bio-Rad Laboratories held a lion’s share in the regional market of about 50% in 2026. The leading companies will show a keen interest in mergers and acquisitions to expand their operations in the region.
According to the research report, the Europe molecular diagnostics market is expected to be worth US$769.0 mn by the end of 2025 from US$395.7 mn in 2016. Between the forecast years of 2017 and 2025, the regional market is expected to register a CAGR of 6.6%. Analysts expect that the real-time PCR systems segment will lead the pack as it is poised to be worth US$482.0 mn by the end of 2025. In terms of geography, Germany is expected to lead the Europe molecular diagnostics market as it accounts for US$185.2 mn in the regional market by the end of 2025.
This 93 page report gives readers a comprehensive overview of the molecular diagnostics market. Browse through 06 data tables and 18 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/europe-molecular-diagnostics-market.html
Increasing Affordability of Diagnostics Propels Growth of Europe Molecular Diagnostics Market
Europe molecular diagnostics market has been burgeoning due to the steady rise of healthcare expenditure. The growing awareness about various chronic diseases and disorders, access of diagnostic centers, and rising affordability of diagnostics are some of the key factors propelling the growth of the regional market. The report states that the increasing support from the government, improving investments in research and development of advanced diagnostics, and high prevalence of infectious diseases are also likely to make a significant contribution to the soaring revenue of the Europe molecular diagnostics market.
The World Cancer Research Fund International states that Denmark registered highest number of cancer cases in Europe in 2012. This was closely followed by France, Belgium, Ireland, and the Netherlands. Thus, the high prevalence of cancer is expected to spike the demand for real-time PCR systems, which are the most preferred assays for the detection of these chronic conditions. The significant rise in product launches in Europe, especially in the field of automated liquid handling systems is likely to augment the demand for lab automation systems. This shift toward automation is expected to benefit market growth in the coming years. Additionally, the partnerships and collaborations between companies and research institutes to offer advanced products are expected to strengthen the market growth over the forecast period.
Difficulty of Sourcing Skilled Labor to Hamper Market Growth
Request a sample of this report to know what opportunities will emerge in the rapidly evolving molecular diagnostics market during 2017 - 2025: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9434
On the flip side, the Europe molecular diagnostics market is being held back by a few factors. The key challenge for the players operating in the regional market is sourcing skilled labor, which is both expensive and scarce. Furthermore, as this skill gap worsens it is likely to make it tougher for the companies to keep their costs reasonable, which, in turn, will adversely impact revenue margins. The constantly growing need for new and improved technologies is also expected to act as an impediment for the molecular diagnostics market in Europe. For instance, adoption of next generation sequencing (NGS) is likely to discourage uptake of real-time PCR systems. Thus, these factors are likely to restrain the market from achieving its full potential. However, the market will have tremendous scope to grow as the demand for non-contact dispensing technologies is poised to augment the sale of liquid dispensing systems in the near future.
This review is based on Transparency Market Research’s report, titled “Molecular Diagnostics Market (Product - Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems; End User - Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Pharmaceutical and Biotechnology Companies) - Europe Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 – 2025.”

Mass Spectroscopy Market: Industry Overview and Key Factors

Global Mass Spectroscopy Market: Overview
The global mass spectroscopy market is poised to rake in a healthy share of the revenue pie with the robust growth of the healthcare sector worldwide. Mass spectroscopy is useful in tracing the distribution of various biomolecules directly from the tissue sample. In addition, it enables testing of multiple diseases and customization of screening programs according to a specific population. Other than healthcare, it finds applications in industries such as food and beverage, biotechnology, and pharmaceutical. Some of the technologies used in mass spectroscopy are matrix-assisted laser desorption/ionization (MALDI), gas and liquid chromatography combined with mass spectrometry, quadrupole mass spectroscopy, and time-of-flight mass spectrometry (TOFMS).
Obtain Report Details: http://www.transparencymarketresearch.com/mass-spectroscopy-market.html
The research report is an outcome of an in-depth analysis of the dynamics and competitive scenario of the global mass spectroscopy market. It sheds light on the trends influencing the market at both global and regional levels.
Global Mass Spectroscopy Market: Drivers and Restraints
Rapid technological advancements are boosting the scope of applications and subsequently the base of end users of mass spectroscopy, thereby augmenting the global market. Moreover, the rising concerns regarding the safety of food products and drugs as a result of growing incidences of related complications are stimulating the demand for analytical methods. This factor is, therefore, stoking the growth of the global mass spectroscopy market.
The increasing research and development activities in fields, including drug development, biomarkers, molecular biology, gene expression studies, and proteomics are also providing a significant momentum to the market. On the other hand, rapid technological advancements are trimming the life cycle of existing products, which is hindering the growth of the global mass spectroscopy market. Furthermore, the high price of devices is limiting the widespread adoption of mass spectroscopy. However, to maximize their revenue generation, market players are expected to tap the immense potential of emerging countries.
Global Mass Spectroscopy Market: Geographical Segmentation
The key regions analyzed in the report are Asia Pacific, North America, Latin America, the Middle East and Africa, and Europe. North America and Europe are anticipated to be major revenue contributors throughout the forecast period. The growth of these regions can be attributed to the presence of a large number of academic and research institutes and the growing investments by governments in the biomedical and biotechnology sectors. In North America, the U.S. will be at the forefront of growth, owing to the domicile of a raft of key participants.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4313
However, there is a gradual shift in focus of key players towards emerging countries, owing to their improving economic conditions. Asia Pacific is estimated to register a noteworthy CAGR during the same period. The growth of the region is largely supplemented by increasing funds allocated by governments for research activities and increasing investments by global players in the countries such as India and China. In Latin America, Brazil will be a sight of high growth rate due to the robust growth of end-user industries.
Global Mass Spectroscopy Market: Competitive Landscape
The degree of competition in the global mass spectroscopy market is anticipated to remain high throughout the forecast period. In order to differentiate their offerings, players are pouring sizeable funds into research and development of novel technologies. Mergers and alliances are looked upon as viable strategies by the majority of participants to expand their shares in the market. Some of the prominent companies operating in the global mass spectroscopy market are PerkinElmer, Dani Instruments S.P.A., Waters Corporation, Shimadzu Corporation, Thermo Fisher Scientific, Agilent Technologies, Kore Technologies Ltd., Danaher Corporation, Bruker Corporation, and Leco Corporation among others.

Urgent Care Centers Industry Perspective and Comprehensive Analysis 2020

AFC/Doctors Express, CareSpot Express Healthcare LLC, Concentra Inc., have been some of the leading players in the global urgent care centers market for 2013, according to a research report released by Transparency Market Research. The degree of competition in the market is likely to intensify over the coming years, thanks to a growth spurt in demand in emerging economies. The market has so far been a fragmented one, with smaller vendors accounting for a large share in the market.
According to TMR, the competitive landscape in the global urgent care centers market is likely to be marked with the leading players expanding their operations to new shores while taking consolidation efforts in the form of mergers and acquisitions. The global urgent care centers market was valued at US$23.5 bn in 2013. Owing to several factors contributing to its growth, the market is projected to reach US$30.5 bn by the end of 2020, after expanding at a CAGR of 3.80% within a forecast period from 2014 to 2020.
This 72 page report gives readers a comprehensive overview of the urgent care centers market. Browse through 06 data tables and 15 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/urgent-care-centers-market.html
Emerging Economies Put Best Foot Forward in Urgent Medical Care Investments
North America and Europe have consistently been the leading regions as far as the global urgent care centers market is concerned. Over the coming years, however, more and more importance is expected to be given to similar medical practices and establishments within emerging economies. Nations such as China, Japan, and India are swiftly ramping up their investments in the healthcare sector and especially into markets such as urgent care centers. These countries are recognizing the need for such centers to become available to the general public at a large scale, in order to improve mortality rates and reduce the spread of infections as well as reduce the number of preventable deaths. Regions such as Latin America, the UAE, Israel, and South Africa are also prime targets for the promotion of urgent care centers over the future.
Rise in Geriatric Population Spurs Demand for Urgent Care Centers
“One of the leading drivers for the global urgent care centers market at the moment is the tremendous count of geriatrics in several key regions. The elderly are considered to be the key patient demographic that is in need of urgent care centers, and a global rise in their numbers is a direct implication of a rise in the demand for these centers. Based on statistics published by global bodies such as WHO and CDC, the number of elderly in the world is not only on an incremental path, but so is the total number of patients suffering from both chronic and infrequent ones. The elderly are especially susceptible to the problems caused by chronic illnesses, a lot of which often require urgent medical attention,” states a TMR analyst.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving urgent care centers market during 2014 - 2020: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2254
Skilled Labor May be Insufficient
While the demand for urgent care centers is increasing around the world, it still remains to be seen if this demand can be met with the provision and availability of skilled medical professionals that can work at these centers. This is especially a problem in several emerging economies, where the lack of skilled labor can slow down the rate of establishment of urgent care centers. Additionally, the market is expected to continue being restrained by the mounting costs of establishing these centers, especially in remote areas. The problem is complicated further due to the constant need for investments in order to stay updated on the latest medical technologies in order to provide the best possible urgent medical attention.
The information presented in this review is based on a Transparency Market Research report, titled, “Urgent Care Centers Market (Services - Illness, Injury, Physical, Vaccination, Diagnostic, and Screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.”

Vitreous Tamponades Industry - Detailed Analysis of Market Structure from 2014 to 2020

Vitreous tamponades are essentials used in vitrectomy procedures conducted in the human eye that either assist in healing/reattachment of the retina or provide a replacement to a clouded vitreous humor. This report studies the current as well as future prospects of the global vitreous tamponades market. The report comprises an elaborate executive summary that includes extensive analysis of the vitreous tamponade products and their market based on applicability, effectiveness, sales revenue and geographic presence. In addition, the executive summary includes a market snapshot, which comprises market trends and dynamics of various market segments that are included in this report. The executive summary chapter also includes a waterfall diagram that reflects the market size of various segments for the year 2013.
This 73 page report gives readers a comprehensive overview of the vitreous tamponades market. Browse through 9 data tables and 15 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/vitreous-tamponades-market.html
The market overview section of the report comprises analysis of the vitreous tamponades market by considering factors that determine the market dynamics such as drivers, restraints and opportunities. This section of the report also includes Porter’s five forces analysis that covers the global market in terms of bargaining power of buyers and suppliers, threat of new entrants and substitutes, and competitive rivalry. In addition, the section comprises market attractiveness analysis that helps gain knowledge about the most attractive and leading geographic region in the global vitreous tamponades market. The market overview section also includes market share analysis of the key players (in terms of value %) operating in the vitreous tamponades market for the year 2013, and value chain analysis that studies major steps involved in the preparation and distribution of vitreous tamponades by manufacturers.
Based on types, the vitreous tamponades market has been segmented into gaseous tamponades and liquid tamponades. The liquid tamponades segment has been further sub-segmented into silicone oil and perfluorocarbon liquids. The gaseous tamponades segment on the other hand includes market revenue of SF6 and C3F8 collectively. The market for these two types of vitreous tamponades has been extensively analyzed based on factors such as sales revenues, usage pattern, developments and geographic presence. The market size and forecast in terms of revenue (USD million) for each of these types have been provided for the period from 2012 to 2020, considering 2013 as the base year. The report also provides the compound annual growth rate (CAGR) for each segment for the forecast period from 2014 to 2020.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving vitreous tamponades market during 2014 - 2020: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4233
Geographically, the vitreous tamponades market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Each geographical region has been further segmented, based on types of tamponades, into gaseous tamponades and liquid tamponades. The market size and forecast for each of these regions have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The research study also incorporates the competitive scenario in these regions.
The report also provides a heat map analysis of the major players in the vitreous tamponades market have been included. A list of recommendations has been provided for new entrants as well as existing players to help establish a strong presence in the market and increase market shares. The report concludes with profiles of major players in the vitreous tamponades market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Alcon, Inc., Valeant Pharmaceuticals International, Inc. (parent of Bausch + Lomb), Carl Zeiss Meditec AG, Dutch Ophthalmic Research Center B.V., Fluoron GmbH, Croma - Pharma AG, and AL.CHI.MI.A Srl.

U.S. Vaccines Market is Expected to Rise at a Remarkable CAGR During 2014-2020

A vaccine is a biological preparation of killed forms of microbes, living attenuated organisms, living fully virulent organisms, a microbe’s toxins or one of its surface proteins. Vaccines play a key role in improving immunity against particular diseases. Therefore, vaccination is promoted as a vital public health intervention throughout the globe. According to the World Health Organization (WHO), vaccination has reduced the burden of infectious disease globally to a great extent. According to a study conducted by Zhou et al, vaccination prevented 42,000 early deaths and approximately 20 million cases of diseases in children born in the U.S. in 2009, resulting in saving USD 13.5 billion in direct medical and non-medical costs and USD 68.8 billion in total societal costs.
This 83 page report gives readers a comprehensive overview of the U.S. vaccine market. Browse through 26 data tables and 28 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/us-vaccine-market.html
This report on the U.S. vaccine market offers an insightful and in-depth assessment of the current as well as future market potential of human as well as animal vaccine markets. The human vaccine market is further segmented into pediatric and adult vaccine markets, based on vaccine type. On the basis of different antigens, the U.S. human vaccine market has been categorized into hepatitis, influenza, meningococcal, pneumococcal, human papillomavirus (HPV), combination vaccines and others. The U.S. animal vaccine market is broadly segmented as companion animal and livestock vaccine markets. The U.S. companion animal vaccine market segment has been further categorized into canine and feline, while the livestock vaccine market has been divided into porcine, bovine, ovine, poultry and equine markets.
Each of these segments and sub-segments has been extensively analyzed in the report, considering factors such as market trends, recent developments, future outlook and opportunities. The report provides market revenue size in terms of USD million for each segment and sub-segment for the period 2012 to 2020. In addition, the compounded annual growth rate (CAGR) of the overall U.S. vaccine market and various segments and sub-segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 and 2013 as the base years. Extensive pricing analysis for human as well as animal vaccine market has been provided in the report.
This report includes an elaborate executive summary, which covers a market snapshot representing key findings from the study on the U.S. vaccine market. The market overview section of the report on the U.S. vaccine market comprises qualitative analysis of the overall market considering factors determining market dynamics such as growth drivers, restraints and opportunities. The market overview chapter also includes a section describing the vaccine approval and regulatory pathway in the U.S. The competitive landscape section has been provided for both human and animal vaccine markets. This section presents the market revenue share of key players in terms of percentage for the year 2013. The market share analysis of key players involved the study of company product portfolio and sales revenue along with market developments such as new product launch and regulatory approvals.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving U.S. vaccine market during 2014 - 2020: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=553
This study on the U.S. vaccine market suggests a list of recommendations for new companies willing to enter the market and for existing companies to accentuate revenue shares, which is likely to help in the decision-making process. The report concludes with the profiles of major players in the U.S. vaccine market such as GlaxoSmithKline plc, Merck & Co., Inc., Novartis International AG, Pfizer, Ltd., Sanofi, Boehringer Ingelheim and Zoetis, Inc. Each company profile in the report contains information such as company overview, financial overview, product portfolio, business strategies and recent developments. The company overview section comprises basic information about the company such as major business areas, company’s brief history and its establishment year, number of employees and geographical presence. In the financial overview section, information such as selling and general administrative expenses, R&D expenses and annual revenue for the last three consecutive years (2011, 2012 and 2013) has been provided. The business strategies section mentions key strategies adopted by the company in the past to strengthen its position in the vaccine market. The recent development section gives information about the recent happening in the company related with the vaccine market.

New Trends of Microbiology Culture Market with Worldwide Industry Analysis to 2023

The intense rivalry between Merck Millipore, Thermo Fisher, Sigma-Aldrich, and Becton, Dickinson and Co. characterizes the competitive landscape of the global microbiology culture market, finds a research study by Transparency Market Research (TMR). In 2015, these four players held a share of nearly 53% in the overall market.
With leading participants focusing aggressively towards product innovation and reaching new breakthroughs, the competition within the market is likely to remain high over the next few years. These companies are looking to expand their bases to emerging economies, such as India, Brazil, and China, in order to exploit the untapped opportunities they hold.
This 75 page report gives readers a comprehensive overview of the microbiology culture market. Browse to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/microbiology-culture-market.html
According to the research study, the worldwide market for microbiology culture presented an opportunity worth US$4.51 bn in 2014. Progressing at a CAGR of 5.90% during the period from 2015 to 2023, the market is likely to reach US$7.59 bn by the end of the forecast period. Bacterial culture has gained prominence in the global market and is expected to retain it over the period of forecast, expanding at a CAGR of 6.70%.
Significant Rise in Government Funding to Ensure North America’s Lead
The report also analyzes the global market for microbiology culture on its geographical presence. As per the study, Asia Pacific, North America, Europe, the Middle East, Latin America, and the Rest of the World are the main geographical sections of this market. With the significant rise in the government funding to increase research and development activities in microbiology, Europe and North America have emerged as the leading contributors to the global market. Researchers project North America to retain its position with a share of nearly 35% by the end of the forecast period.
On the similar line, Asia Pacific is also anticipated to witness strong growth over the forecast period, thanks to the rise in the disposable income of consumers, advancement in healthcare infrastructure, and the high prevalence of infectious diseases.
Growing usage of Antibiotics in Bacterial and Protozoan Infection Therapeutics to Boost Demand for Microbiology Culture
Request a sample of this report to know what opportunities will emerge in the rapidly evolving microbiology culture market during 2015 - 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3232
“The increasing demand for antibiotics is the key factor behind the rising the practice of microbiology culture,” states the author of this study. With the growing usage of antibiotics for the treatment of various bacterial and protozoan infections, the need for its large-scale production has increased substantially as the available quantity of naturally-occurring antibiotics is very less. As a result, microbes are being cultured under controlled conditions to raise their biomass and separate antibiotics from them, which eventually, is leading to a remarkable rise of the global microbiology culture market.
On the flip side, the high costs of culture media and the constant operation of fermentation vessel over a number of weeks may create obstacles to the growth of this market over the next few years. The difficult procedure of alternative nutrient source identification for the progression of various microorganisms in a bid to meet the exact requirements and the urgent need to decrease the cost of large-scale fermentation are also projected to limit microbial culture practices in the coming years, states the research report.
The study presented here is based on a report by Transparency Market Research (TMR) titled “Microbiology Culture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015–2023.”